Therapy of Metastatic Melanoma with BRAF Inhibitors

被引：0
|
作者：
Hafner, C. [1 ]
机构：
[1] Univ Regensburg, Klin & Poliklin Dermatol, D-93053 Regensburg, Germany
来源：
HAUTARZT | 2011年 / 62卷 / 09期
关键词：
RAF; RESISTANCE; MUTATIONS; PATHWAY; NEVI;
D O I：
10.1007/s00105-011-2232-8
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：696 / 698
页数：3
相关论文
共 50 条
  • [1] Empiric Therapy with BRAF and MEK Inhibitors in Metastatic Melanoma
    Cann, Christopher G.
    Tillman, Benjamin F.
    Davis, Elizabeth J.
    Johnson, Douglas B.
    ONCOLOGIST, 2019, 24 (11): : 1495 - 1496
  • [2] Overcoming Metastatic Melanoma with BRAF Inhibitors
    Hong, Seunghee
    Hong, Sungwoo
    Han, Sang-Rae
    ARCHIVES OF PHARMACAL RESEARCH, 2011, 34 (05) : 699 - 701
  • [3] Overcoming metastatic melanoma with BRAF inhibitors
    Seunghee Hong
    Sungwoo Hong
    Archives of Pharmacal Research, 2011, 34 : 699 - 701
  • [4] Commentary: BRAF inhibitors for metastatic melanoma
    Marples, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2013, 168 (03) : 471 - 473
  • [5] The utility of BRAF inhibitors in metastatic melanoma to brain
    O'Reilly, A.
    Gleeson, C. G.
    Redmond, H. P. R.
    Fitzgibbon, J.
    O'Regan, K. O. R.
    Barry, J. B.
    Power, D. G. P.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S871 - S871
  • [6] Documenting the histologic response of metastatic melanoma to combination therapy with BRAF and MEK inhibitors
    Mieczkowska, Karolina
    Jacob, Jack
    Paoluzzi, Luca
    Papalezova, Katia T.
    McLellan, Beth N.
    Amin, Bijal
    MELANOMA RESEARCH, 2022, 32 (02) : 128 - 129
  • [7] Cardiovascular monitoring in metastatic melanoma patients undergoing combination therapy with BRAF and MEK inhibitors
    Guglielmi, Giulia
    Sarocchi, Matteo
    Tini, Giacomo
    Schiavone, Arianna
    Toma, Matteo
    Spagnolo, Francesco
    Tanda, Enrica Teresa
    Boutros, Andrea
    Spallarossa, Paolo
    Porto, Italo
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0N) : N20 - N21
  • [8] BRAF and MEK inhibitors in therapy of advanced melanoma
    Kosela, Hanna
    Switaj, Tomasz
    Rutkowski, Piotr
    ONCOLOGY IN CLINICAL PRACTICE, 2011, 7 (05): : 246 - 253
  • [9] The Evaluation of Immune Checkpoint Inhibitors and BRAF/MEK Inhibitors in Different Therapy Lines for Metastatic Melanoma: A Retrospective Study
    Okuda-Hiwatashi, Saki
    Amagai, Ryo
    Fujimura, Taku
    Kambayashi, Yumi
    Watanabe-Takahashi, Manami
    Yamazaki, Emi
    Tamabuchi, Erika
    Itabashi, Chisato
    Hashimoto, Akira
    Asano, Yoshihide
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (18)
  • [10] Patterns of treatment and BRAF testing with immune checkpoint inhibitors and targeted therapy in patients with metastatic melanoma presumed to be BRAF positive
    Ghate, Sameer
    Ionescu-Ittu, Raluca
    Burne, Rebecca
    Ndife, Briana
    Laliberte, Francois
    Nakasato, Antonio
    Duh, Mei Sheng
    MELANOMA RESEARCH, 2019, 29 (03) : 301 - 310
12345